Most investors overlooked the licensing loophole. That was a mistake.
The draft guidelines require any AI company seeking federal contracts to grant the United States an irrevocable, all‑purpose license to its models. In plain terms, the government could run, modify, and redistribute the technology for any legal use without further permission or compensation. This unprecedented breadth raises three core concerns for shareholders.
1. Dilution of Intellectual Property Value – AI models are the primary assets on a balance sheet. When a firm must hand over an unrestricted license, the future cash flows tied to exclusive licensing, premium SaaS pricing, and strategic partnerships evaporate. The market typically prices IP risk at 15‑25% of enterprise value; an irrevocable license could double that discount.
2. Heightened Competitive Exposure – A rival could reverse‑engineer a licensed model, accelerating its own R&D timeline. This reduces the competitive moat that justified lofty multiples for companies like Anthropic, OpenAI, and emerging startups.
3. Legal and Compliance Costs – Ongoing monitoring to ensure compliance with “any lawful use” adds administrative overhead and potential litigation risk, eroding margins.
While AI firms bear the direct brunt, the policy’s reach extends to adjacent markets.
Cloud Platforms – Amazon Web Services, Microsoft Azure, and Google Cloud host most AI workloads. If their customers lose exclusive rights, demand for premium AI‑optimized instances could drop, pressuring top‑line growth.
Semiconductor Makers – Nvidia, AMD, and specialized AI chip producers sell GPUs and ASICs on the promise of proprietary model performance. A licensing regime that democratizes model access may flatten the price premium for high‑end chips.
Defense Contractors – Companies like Lockheed Martin and Raytheon have been courting AI firms to embed advanced analytics in weapons systems. The new rule could either accelerate contracts (by simplifying legal clearance) or deter AI vendors wary of losing control, creating a bifurcated market.
In the early 2000s, the U.S. tightened export controls on semiconductor equipment to China. The move shocked investors, prompting a 12% sell‑off in chip stocks before the market re‑priced the risk. A similar pattern could emerge here: an initial shock, followed by a period of volatility as analysts reassess cash‑flow models.
Two lessons emerge:
An irrevocable license is a legal instrument that cannot be withdrawn once granted. It differs from a revocable, time‑limited contract that parties can renegotiate. In the AI context, the clause "any lawful use" is deliberately broad, encompassing research, commercial deployment, and even resale to third parties. Investors should scrutinize each company’s contract language, as even slight variations can materially affect risk exposure.
Bull Case – Companies that proactively negotiate favorable terms—limiting scope, securing royalty arrangements, or bundling licensing with exclusive data rights—could retain upside. Look for firms with strong legal teams, pre‑existing DoD contracts, or those that can pivot to proprietary on‑premise offerings for commercial customers.
Bear Case – AI startups lacking deep pockets for legal negotiations may be forced into blanket licenses, eroding their competitive edge. Their stock could suffer double‑digit declines, especially if they rely heavily on government revenue.
Strategic actions for investors:
By mapping the regulatory landscape to cash‑flow forecasts, you can stay ahead of the market’s next move.